Böhm R and Giessler AJ |
[Thrombocyte aggregation inhibitors. A new class of active substances]. |
1986 |
Pharmazie |
pmid:3515372
|
Vieweg H et al. |
[Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)-amidines by the reaction with 4-oxo-4H-pyrido(3',2':4,5)-thieno(3,2-d)-1,3-oxazines with secondary cycloaliphatic amines]. |
1992 |
Pharmazie |
pmid:1492113
|
Kertscher HP and Ostermann G |
[Synthesis and thrombocyte aggregating action of stereoisomers of PAF-acether]. |
1986 |
Pharmazie |
pmid:3786385
|
Kertscher HP and Ostermann G |
[Synthesis and biological activity of isomeric structural analogs of platelet activating factor]. |
1985 |
Pharmazie |
pmid:3991788
|
Kertscher HP |
[PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship]. |
1997 |
Pharmazie |
pmid:9411454
|
Kertscher HP et al. |
[PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements]. |
1991 |
Pharmazie |
pmid:1798710
|
Asai Y |
Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880. |
2005 |
Pharmazie |
pmid:15801673
|
Kertscher HP et al. |
[PAF-antagonists with a phospholipid structure. 5. Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variations of the phosphorus-nitrogen distance;synthesis, characterization and structure activity relationship]. |
1993 |
Pharmazie |
pmid:8460172
|
Ostermann G et al. |
[Platelet activating factor--a biologically active phospholipid]. |
1990 |
Pharmazie |
pmid:2236190
|
Wagner G et al. |
[Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)-formamidines corresponding alkyl esters with antianaphylactic activity]. |
1993 |
Pharmazie |
pmid:8493283
|
Chatterjee SS et al. |
Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. |
2003 |
Pharmacopsychiatry |
pmid:13130392
|
Ueno M et al. |
Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen. |
1998 |
Pharmacology |
pmid:9730778
|
Shibamoto T et al. |
PAF, rather than histamine, participates in mouse anaphylactic hypotension. |
2008 |
Pharmacology |
pmid:18583921
|
Kagoshima M et al. |
Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs. |
1997 |
Pharmacology |
pmid:9065955
|
Singh N et al. |
Possible mechanism of alprazolam-induced amnesia in mice. |
1998 |
Pharmacology |
pmid:9467187
|
Merlos M et al. |
Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents. |
1990 |
Pharmacology |
pmid:1697076
|
Kagoshima M et al. |
Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. |
1997 |
Pharmacology |
pmid:9380772
|
Achterrath-Tuckermann U et al. |
Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction. |
1988 |
Pharmacology |
pmid:3380879
|
Suzuki S et al. |
Effect of a platelet-activating factor antagonist, WEB 2086, on inhibition of active oxygen generation in human polymorphonuclear leukocytes. |
1994 |
Pharmacology |
pmid:8134402
|
Capasso F et al. |
Effect of senna is not mediated by platelet-activating factor. |
1993 |
Pharmacology |
pmid:8234442
|
Cheng HH et al. |
Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus. |
2005 |
Pharmacology |
pmid:15591819
|
Pei HX et al. |
Ginkgolide B Reduces the Degradation of Membrane Phospholipids to Prevent Ischemia/Reperfusion Myocardial Injury in Rats. |
2015 |
Pharmacology |
pmid:26382046
|
Bannenberg G et al. |
Hydrogen peroxide-induced broncho- and vasoconstriction in the isolated perfused and ventilated guinea pig lung. |
1993 Apr-May |
Pharmacol. Toxicol. |
pmid:8372054
|
Cakici I et al. |
Effects of platelet-activating factor antagonists WEB 2086 and BN 50730 on digoxin-induced arrhythmias. |
1995 |
Pharmacol. Toxicol. |
pmid:7479573
|
Chen SF and Ruan YJ |
1 alpha,25-Dihydroxyvitamin D3 decreases scalding- and platelet-activating factor-induced high vascular permeability and tissue oedema. |
1995 |
Pharmacol. Toxicol. |
pmid:7479576
|
Moilanen E and Kankaanranta H |
Tolfenamic acid and leukotriene synthesis inhibition. |
1994 |
Pharmacol. Toxicol. |
pmid:7816785
|
Abu-Zidan FM et al. |
BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs. |
1996 |
Pharmacol. Toxicol. |
pmid:8685082
|
Monteiro HS et al. |
Glomerular effects of cholera toxin in isolated perfused rat kidney: a potential role for platelet activating factor. |
1999 |
Pharmacol. Toxicol. |
pmid:10522748
|
Morley J et al. |
Platelet activating factor and airway smooth muscle. |
1989 |
Pharmacol. Ther. |
pmid:2646651
|
Williams FM |
Neutrophils and myocardial reperfusion injury. |
1996 |
Pharmacol. Ther. |
pmid:8981567
|
Braquet P et al. |
Perspectives in platelet-activating factor research. |
1987 |
Pharmacol. Rev. |
pmid:3303066
|
Saeed SA et al. |
Anti-thrombotic and anti-inflammatory activities of protopine. |
1997 |
Pharmacol. Res. |
pmid:9368908
|
Caruso A et al. |
Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema. |
1995 |
Pharmacol. Res. |
pmid:7784308
|
SariahmetoÄŸlu M et al. |
Effects of WEB 2086 on the protective role of preconditioning against arrhythmias in rats. |
1998 |
Pharmacol. Res. |
pmid:9782066
|
Qian C et al. |
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. |
2001 |
Pharmacol. Res. |
pmid:11529688
|
Mest HJ et al. |
WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity. |
1990 Jul-Aug |
Pharmacol. Res. |
pmid:2402478
|
Lagente V et al. |
Protective effect of a specific platelet-activating factor antagonist, BN 52021, on bupivacaine-induced cardiovascular impairments in rats. |
1989 Sep-Oct |
Pharmacol. Res. |
pmid:2594614
|
Mest HJ et al. |
Effect of BN 52256 and other mediator antagonists on ouabain-induced cardiac arrhythmia in a model of anaphylaxis in guinea-pigs. |
1992 Feb-Mar |
Pharmacol. Res. |
pmid:1635894
|
Lograno MD et al. |
Effects of prostaglandins and PAF on the contractility of the bovine ciliary muscle. |
1992 Feb-Mar |
Pharmacol. Res. |
pmid:1635897
|
Montesi L et al. |
Human platelet activation by PAF: receptor characterization. |
1989 Nov-Dec |
Pharmacol. Res. |
pmid:2561199
|
Berti F et al. |
Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivatives. |
1986 |
Pharmacol Res Commun |
pmid:3749244
|
Foegh ML et al. |
The causal role of PAF and leukotrienes in acute cardiac allograft rejection in rats. |
1986 |
Pharmacol Res Commun |
pmid:3534895
|
Brambilla A et al. |
WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage. |
1987 |
Pharmacol Res Commun |
pmid:3588650
|
Baranes J et al. |
The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. |
1986 |
Pharmacol Res Commun |
pmid:3763677
|
Danko G et al. |
Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis. |
1988 |
Pharmacol Res Commun |
pmid:3174804
|
Bussolino F et al. |
Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. |
1986 |
Pharmacol Res Commun |
pmid:3490673
|
Riedel A et al. |
The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity. |
1987 |
Pharmacol Res Commun |
pmid:3441484
|
Godfroid JJ et al. |
Synthesis of ether phospholipids. |
1986 |
Pharmacol Res Commun |
pmid:3774838
|
|
PAF and leukotrienes '85. Proceedings of the meeting. Paris, September 27th 1985. |
1986 |
Pharmacol Res Commun |
pmid:3774839
|
Vilain B et al. |
Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. |
1986 |
Pharmacol Res Commun |
pmid:3774840
|
Bessin P |
PAF-acether and leukotriene participation in acute circulatory shock. |
1986 |
Pharmacol Res Commun |
pmid:3774841
|
Goldstein RE et al. |
Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. |
1986 |
Pharmacol Res Commun |
pmid:3774842
|
Plante GE et al. |
Hemodynamic effects of PAF-acether. |
1986 |
Pharmacol Res Commun |
pmid:3774843
|
Sanchez Crespo M et al. |
Evidence of a role for PAF-acether in the pathophysiology of the shock state. |
1986 |
Pharmacol Res Commun |
pmid:3774844
|
Adnot S et al. |
Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. |
1986 |
Pharmacol Res Commun |
pmid:3774845
|
Rainsford KD |
Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration. |
1986 |
Pharmacol Res Commun |
pmid:3774846
|
Page CP and Morley J |
Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma. |
1986 |
Pharmacol Res Commun |
pmid:3774847
|
Haye-Legrand I et al. |
Production of PAF-acether and leukotrienes by cultured mouse macrophages. |
1986 |
Pharmacol Res Commun |
pmid:3774848
|
Dupont L et al. |
Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. |
1986 |
Pharmacol Res Commun |
pmid:3774849
|
Bruynzeel PL et al. |
Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils. |
1986 |
Pharmacol Res Commun |
pmid:3774850
|
Etienne A et al. |
The relative role of PAF-acether and icosanoids in septic shock. |
1986 |
Pharmacol Res Commun |
pmid:3774851
|
Maes L et al. |
Endogenic PAF-acether production by guinea pig endothelial cells in experimental arterial thrombosis. |
1986 |
Pharmacol Res Commun |
pmid:3774852
|
Uhlig S et al. |
Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. |
2005 |
Pharmacol Rep |
pmid:16415501
|
Stafforini DM |
PAF acetylhydrolase gene polymorphisms and asthma severity. |
2001 |
Pharmacogenomics |
pmid:11535107
|
Semini G et al. |
Impact of alkylphospholipids on the gene expression profile of HaCaT cells. |
2011 |
Pharmacogenet. Genomics |
pmid:21681147
|
Weber N |
[A platelet-activating factor--a physiologically active ether lipid]. |
1986 |
Pharm Unserer Zeit |
pmid:3749211
|
Nordin N et al. |
Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum. |
2012 |
Pharm Biol |
pmid:22103812
|
Alonso-Torre SR and Trautmann A |
Rapid refilling of Ca2+ stores in macrophages stimulated by ATP involves the sequential activation of phospholipase D and protein kinase C. |
1995 |
Pflugers Arch. |
pmid:7675633
|
Randriamampita C et al. |
Cyclic-GMP-dependent refilling of calcium stores in macrophages. |
1991 |
Pflugers Arch. |
pmid:1647519
|
Kester M et al. |
The potentiation of arterial contraction with platelet activating factor. |
1984 |
Pflugers Arch. |
pmid:6718228
|
Hermoso M et al. |
Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. |
2001 |
Pflugers Arch. |
pmid:11484763
|
Asimakopoulos G et al. |
Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin. |
2000 |
Perfusion |
pmid:11131212
|
Quigley RL et al. |
Cardiopulmonary bypass with adequate flow and perfusion pressures prevents endotoxaemia and pathologic cytokine production. |
1995 |
Perfusion |
pmid:7795310
|
Sung CP et al. |
CGRP stimulates the adhesion of leukocytes to vascular endothelial cells. |
1992 May-Jun |
Peptides |
pmid:1326102
|
Cox CP et al. |
VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). |
1984 Mar-Apr |
Peptides |
pmid:6206481
|
Sato A et al. |
Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats. |
2015 |
Peptides |
pmid:26348270
|
Pirotzky E et al. |
[Renal diseases and platelet activating factor]. |
1989 |
Pediatrie |
pmid:2740184
|
Ozturk H et al. |
PAF antagonist BN-52021 reduces intercellular adhesion molecule-1 expression and oxidative stress in rats with reperfusion damage due to unilateral testicular torsion. |
2006 |
Pediatr. Surg. Int. |
pmid:16369775
|
McFall TL et al. |
Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction. |
1987 |
Pediatr. Res. |
pmid:3037472
|
Caplan MS et al. |
Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. |
2001 |
Pediatr. Res. |
pmid:11328947
|
Wang H et al. |
Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: effect of cycloheximide. |
1997 |
Pediatr. Res. |
pmid:9357930
|
Liu XH et al. |
Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. |
2001 |
Pediatr. Res. |
pmid:11385142
|
Claud EC et al. |
Platelet-activating factor regulates chloride transport in colonic epithelial cell monolayers. |
2002 |
Pediatr. Res. |
pmid:12149490
|
Brus F et al. |
Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. |
1996 |
Pediatr. Res. |
pmid:8929866
|
Liu XH et al. |
The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. |
1996 |
Pediatr. Res. |
pmid:8947953
|
Stambouly JJ et al. |
Sustained effects of platelet-activating factor infusion in piglets. |
1991 |
Pediatr. Res. |
pmid:1945566
|
Kikawa Y et al. |
Leukotriene B4 biosynthesis in polymorphonuclear leukocytes from blood of umbilical cord, infants, children, and adults. |
1986 |
Pediatr. Res. |
pmid:3012451
|
Harris MC et al. |
Diminished actin polymerization by neutrophils from newborn infants. |
1993 |
Pediatr. Res. |
pmid:8433856
|
Tan ND and Davidson D |
Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn. |
1995 |
Pediatr. Res. |
pmid:7478787
|
MacKendrick W et al. |
Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. |
1993 |
Pediatr. Res. |
pmid:8233729
|
Furukawa M et al. |
Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. |
1993 |
Pediatr. Res. |
pmid:8233731
|
Bradley LM et al. |
Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses. |
1989 |
Pediatr. Res. |
pmid:2587116
|
Lu J et al. |
Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. |
2010 |
Pediatr. Res. |
pmid:20531249
|
Viswanath M et al. |
Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection. |
2000 |
Pediatr. Res. |
pmid:10879808
|
Caplan MS et al. |
Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor. |
1992 |
Pediatr. Res. |
pmid:1603619
|
Abraham WM and Wanner A |
Inflammatory mediators of asthma. |
1988 |
Pediatr. Pulmonol. |
pmid:2455882
|
Smith JM et al. |
Platelet-activating factor and Escherichia coliO157:H7 infections. |
2002 |
Pediatr. Nephrol. |
pmid:12478356
|
Svetlov SI et al. |
Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome. |
1999 |
Pediatr. Nephrol. |
pmid:10353406
|
Hsueh W et al. |
Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. |
2003 Jan-Feb |
Pediatr. Dev. Pathol. |
pmid:12424605
|
Hsueh W et al. |
Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective. |
1998 Jan-Feb |
Pediatr. Dev. Pathol. |
pmid:10463267
|